Stay updated with breaking news from Wesley Yip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer. Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer.
Neoadjuvant gemcitabine-cisplatin produced a “favorable” pathologic response rate in patients with high-grade upper tract urothelial carcinoma.
Neoadjuvant gemcitabine-cisplatin produced a “favorable” pathologic response rate in patients with high-grade upper tract urothelial carcinoma.